Delivery Order SPE2DB20D2104-SPE2DB24FT52Q

Award Date 4/9/24
Potential Completion Date 4/10/24
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,154.11, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $17,126.81 and is a firm fixed-price delivery order with a period of performance ending on February 7, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $15,264.76 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 30, 2025, with a completion date of January 31, 2025. The contract has a firm fixed price of $18,880.79 and is a delivery order contract type. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $11,396.55 and a completion date of December 12, 2024. It is not designated as a set-aside contract. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $37,989.64, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $6,801.22. The contract is a delivery order with a firm fixed price, and the ultimate completion date is March 4, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $24,488.75, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 17, 2023, with an ultimate completion date of August 18, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $12,078.82, was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 2, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the supply of Jardiance 10 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $25,690.57, with a firm fixed price. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FT52Q
    Delivery Order

This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $7,763.13, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999 IDC running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. The contract will be completed by April 10, 2024.

Generated 2/27/25, 11:40 AM